Headlines | WebDisclosure

Basculer en Français

8302	Companies
115129	Keywords
55450	Articles
62533	Press releases

BRIEF

published on 11/22/2024 at 00:05, 3 hours 54 minutes ago

Gratomic Provides Update on Aukam Graphite Mine and Board Changes

Graphite Supply Gratomic Aukam Graphite Mine Hermanus Manuel Silver Kobus La Grange
BRIEF

published on 11/22/2024 at 00:05, 3 hours 54 minutes ago

Gratomic fournit des informations actualisées sur la mine de graphite d'Aukam et les changements au sein du conseil d'administration

Approvisionnement En Graphite Gratomique Hermanus Manuel Silver Kobus La Grange Mine De Graphite D'Aukam
PRESS RELEASE

published on 11/22/2024 at 00:00, 3 hours 59 minutes ago

Gratomic Announces Company and Operational Update
Gratomic Inc. provides updates on Aukam Graphite mine production, appoints Hermanus Manuel Silver as COO and Director, and announces board changes and strategic initiatives

Board Changes Mining Operations Gratomic Inc. Hermanus Manuel Silver Aukam Graphite
BRIEF

published on 11/21/2024 at 22:10, 5 hours 49 minutes ago

Protagonist Therapeutics Nominates PN-881 for Immune-Mediated Skin Disorders

Protagonist Therapeutics IL-17 Antagonist PN-881 Skin Diseases Phase I Trials
BRIEF

published on 11/21/2024 at 22:10, 5 hours 49 minutes ago

Protagonist Therapeutics nomme le PN-881 pour le traitement des troubles cutanés à médiation immunitaire

Thérapeutique Protagoniste Antagoniste De L'IL-17 PN-881 Maladies De La Peau Essais De Phase I
BRIEF

published on 11/21/2024 at 22:05, 5 hours 54 minutes ago

Inventiva's Financial Overview for Q3 2024

Financial Results Cash Position Equity Raise Royalty Certificates R&D Expenses
BRIEF

published on 11/21/2024 at 22:05, 5 hours 54 minutes ago

Bilan financier d'Inventiva pour le troisième trimestre 2024

Résultats Financiers Augmentation De Capital Situation De Trésorerie Dépenses De Recherche Et Développement Certificats De Redevances
PRESS RELEASE

published on 11/21/2024 at 22:05, 5 hours 54 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Protagonist Therapeutics announces selection of PN-881, an oral peptide interleukin-17 antagonist, as a development candidate for immune-mediated skin diseases. IND enabling studies ongoing with Phase I expected in Q425

Protagonist Therapeutics IL-17 Antagonist PN-881 Oral Peptide Immune-mediated Skin Diseases
PRESS RELEASE

published on 11/21/2024 at 22:00, 5 hours 59 minutes ago

Inventiva reports 2024 Third Quarter Financial Information¹
Inventiva reports strong financial position with €13.9 million cash at September 30, 2024. R&D expenses down 10% in 2024. Key milestones and future conference participation announced

Financial Information Cash Position Inventiva R&D Expenses Key Milestones
PRESS RELEASE

published on 11/21/2024 at 22:00, 5 hours 59 minutes ago

Inventiva publie ses informations financières du 3ème trimestre 2024¹
Inventiva publie ses informations financi\u00e8res du 3\u00e8me trimestre 2024 avec tr\u00e9sorerie de 13,9 millions d'euros, chiffre d'affaires de 1,3 million sur neuf mois, \u00e9mission de certificats de redevance, pr\u00e9visions de financement jusqu'en 2025

Chiffre D'affaires Financement Inventiva Informations Financi\u00e8res Tr\u00e9sorerie

Accesswire

Published on 11/22/2024 at 00:00, 3 hours 59 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 5 hours 54 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 6 hours 9 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 7 hours 44 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 7 hours 49 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 8 hours 57 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 9 hours 23 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 10 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 10 hours 7 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 10 hours 7 minutes ago

LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.

Les Echos

Published on 11/21/2024 at 06:58, 21 hours 1 minute ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 21 hours 1 minute ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 21 hours 1 minute ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 7 hours ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 8 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE